逆势增长再攀峰，复星联合健康保险多维布局筑牢健康保障新生态

Core Viewpoint - In 2025, the professional health insurance market is undergoing a deep adjustment amid slowing industry growth, intensified competition, and upgraded demand. Fosun United Health Insurance is focusing on the "insurance + medical + health management" strategy, achieving breakthroughs in scale and profitability, demonstrating resilience and vitality in high-quality growth, and injecting new momentum into the industry's transformation [1] Group 1: Performance and Financials - In 2025, the company's insurance business revenue reached 7.84 billion, a year-on-year increase of 50%, ranking among the top in growth among professional health insurance companies [2] - The company achieved a net profit of 130 million, marking five consecutive years of profitability, reflecting continuous optimization in operational efficiency and resource integration [2] - By the end of 2025, the company's total asset scale reached 24.1 billion, with net assets of 3 billion, further enhancing its capital strength [2] Group 2: Product Innovation - The company launched the industry's first full lifecycle managed critical illness insurance "Rui Xing Bao" in collaboration with Ruijin Hospital, focusing on "health management in advance" [3] - This product integrates insurance protection with professional medical services, utilizing smart wearable devices and the "Rui Bao Health" app to create a comprehensive health support system covering prevention, diagnosis, and rehabilitation [3] - The innovation shifts insurance services from "post-event compensation" to "proactive management," enhancing the professionalism and credibility of health insurance services through the empowerment of public medical resources [3] Group 3: Capital Strength - In September 2025, the company completed a strategic capital increase of 810 million, raising its registered capital to 1.01085 billion, and successfully introduced international strategic investors such as the International Finance Corporation (IFC) and the Asian Development Bank (ADB) [4] - The diversified shareholder structure brings international risk control concepts, project experience in the health sector, and medical ecosystem resources, further strengthening the synergy of "insurance + medical" [4] - By the fourth quarter of 2025, the company's core solvency adequacy ratio reached 121.05%, and the comprehensive solvency adequacy ratio reached 173.25%, significantly enhancing its capital strength to support business expansion and innovation [4] Group 4: Investment Capability - The company adheres to a long-term value investment philosophy, constructing a portfolio primarily composed of liquid and fixed-income assets, with moderate equity asset allocation [5] - The average investment return rate over the past three years reached 5.08%, and the average comprehensive investment return rate reached 7.09%, placing it at the leading level in the industry [5] - This demonstrates the company's ability to navigate through cycles, providing stable support for profit growth and customer protection [5] Group 5: Ecosystem Collaboration - The achievements in 2025 stem from the company's continuous deepening of the "insurance + medical + health management" ecosystem strategy [6] - The company aims to leverage its capital strength, service capabilities, and ecological layout to actively respond to the "Healthy China 2030" strategy, focusing on inclusive insurance, grassroots health coverage, chronic disease management, and elderly care [6] - The company seeks to contribute to the construction of a national health security system through innovative services and ecosystem collaboration [6]